Open | $10.100 |
Close | $10.640 |
Volume / Avg. | 1.507M / 1.280M |
Day Range | 9.800 - 10.890 |
52 Wk Range | 2.310 - 13.990 |
Market Cap | $771.122M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 10.04% |
Days to Cover | 5.29 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Fusion Pharmaceuticals (NASDAQ: FUSN) through any online brokerage.
Other companies in Fusion Pharmaceuticals’s space includes: Cabaletta Bio (NASDAQ:CABA), Cogent Biosciences (NASDAQ:COGT), Pharming (NASDAQ:PHAR), Fate Therapeutics (NASDAQ:FATE) and AnaptysBio (NASDAQ:ANAB).
The latest price target for Fusion Pharmaceuticals (NASDAQ: FUSN) was reported by RBC Capital on Monday, March 4, 2024. The analyst firm set a price target for 16.00 expecting FUSN to rise to within 12 months (a possible 50.23% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Fusion Pharmaceuticals (NASDAQ: FUSN) is $10.65 last updated March 18, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Fusion Pharmaceuticals.
Fusion Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Fusion Pharmaceuticals.
Fusion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.